US20130267993A1 - Embolic protection device and method of use - Google Patents

Embolic protection device and method of use Download PDF

Info

Publication number
US20130267993A1
US20130267993A1 US13/911,692 US201313911692A US2013267993A1 US 20130267993 A1 US20130267993 A1 US 20130267993A1 US 201313911692 A US201313911692 A US 201313911692A US 2013267993 A1 US2013267993 A1 US 2013267993A1
Authority
US
United States
Prior art keywords
deflector
artery
deflection device
branch vessel
cover
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US13/911,692
Inventor
Judith T. Carpenter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Edwards Lifesciences AG
Original Assignee
Edwards Lifesciences AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Edwards Lifesciences AG filed Critical Edwards Lifesciences AG
Priority to US13/911,692 priority Critical patent/US20130267993A1/en
Assigned to EMBRELLA CARDIOVASCULAR, INC. reassignment EMBRELLA CARDIOVASCULAR, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: CARPENTER, JUDITH, MD
Assigned to EMBRELLA CARDIOVASCULAR, INC. reassignment EMBRELLA CARDIOVASCULAR, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: CARPENTER, JUDITH T.
Assigned to EDWARDS LIFESCIENCES AG reassignment EDWARDS LIFESCIENCES AG ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: EMBRELLA CARDIOVASCULAR, INC.
Publication of US20130267993A1 publication Critical patent/US20130267993A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/01Filters implantable into blood vessels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/01Filters implantable into blood vessels
    • A61F2002/018Filters implantable into blood vessels made from tubes or sheets of material, e.g. by etching or laser-cutting
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0002Two-dimensional shapes, e.g. cross-sections
    • A61F2230/0004Rounded shapes, e.g. with rounded corners
    • A61F2230/0006Rounded shapes, e.g. with rounded corners circular
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0063Three-dimensional shapes
    • A61F2230/0073Quadric-shaped
    • A61F2230/008Quadric-shaped paraboloidal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0063Three-dimensional shapes
    • A61F2230/0093Umbrella-shaped, e.g. mushroom-shaped

Definitions

  • Endovascular procedures are being used more and more frequently to treat various cardiac and vascular surgical problems.
  • Blocked arteries can be treated with angioplasty, endarterectomy, and/or stenting, using minimally invasive endovascular approaches.
  • Aneurysms can be repaired by endovascular techniques.
  • Another use for endovascular surgery is the treatment of cardiac valvular disease.
  • Valvuloplasties are already being done endovascularly and percutaneous valve replacement will surely follow, as it has already been tested in Europe.
  • a major problem which is common to all these endovascular manipulations is that plaque found in the diseased vessels and valves can be dislodged and result in embolization.
  • the majority of devices described are filters.
  • the problems with filters include difficulty in placement and retrieval as well as the possibility that a filter will fill abruptly causing blockage of the artery prior to removal of the filter.
  • Cerebral protection requires placement of filters in the carotid arteries, which has the additional drawback of manipulation of the carotid vessels during filter placement while the cerebral vasculature is still unprotected.
  • the risk of stroke for a carotid arteriogram done by cannulation of the carotid artery is 1% compared to an arteriogram done from injection into the aorta without selective cannulation which carries minimal risk.
  • the present invention comprises a deflector umbrella.
  • the invention is placed into the aortic arch by the Seldinger technique, preferably through the right arm but it may also be placed via the femoral artery. It is deployed in the aortic arch, where the umbrella is opened and pulled back into position to cover the ostia of both the brachiocephalic and left common carotid arteries.
  • FIG. 1 depicts brachial artery insertion of the deflector of the present invention.
  • FIG. 2 depicts femoral artery insertion of the deflector of the present invention.
  • FIGS. 3A-E depict the preferred method of deployment of the deflector of the present invention through the patient's right arm, thus allowing the deflector to be pulled back against the aortic wall to place it.
  • FIGS. 4A-F depict an alternative method of deployment of the deflector of the present invention through the femoral artery wherein the deflector is pushed against the aortic wall over the brachiocephalic and left common carotid openings.
  • FIG. 5 depicts the deflector of the present invention.
  • the deflector (“umbrella”) of the present invention is positioned prior to any manipulation of the heart or thoracic aorta. It is simple to place and carries only the risk of catheterizing the aorta through the arm or leg, which is minimal.
  • the umbrella is opened in the thoracic aorta and positioned to cover the ostia of both the brachiocephalic and left common carotid arteries. This position prevents clots or debris from entering the cerebral circulation through either the right or left carotid arteries with one simple device. Any debris from the cardiac or aortic procedure is deflected downstream.
  • the umbrella is inverted by means of a sheath extended over the catheter wire, which then wholly or partially covers the inverted umbrella prior to withdrawal. Should any clot or debris be attached to the outer side of the umbrella, it will be captured in the inverted umbrella and withdrawn.
  • a major advantage of the device is that one size fits all, so it can be kept available in stock.
  • the umbrella is preferably dome-shaped with an adequate diameter to cover the ostia of both the brachiocephalic and left common carotid arteries, made of a material with pores or similar openings or permeability to allow the flow of blood into the cerebral circulation, but able to deflect or trap particles of a size which could cause a stroke (as depicted in FIG. 5 .)
  • the edge of the umbrella is preferably a flexible, porous donut shape, similar to the edge of a vaginal diaphragm, allowing a good seal with the curved aortic wall.
  • the edge will preferably contain a nitinol wire ring.
  • the dome part of the umbrella preferably has struts or ribs to assist in the opening and closing of the umbrella and to help maintain its position.
  • the center of the umbrella preferably has a knob or similar projection on the inside surface to which the struts are attached.
  • the deflector is pushed out of the delivery catheter with a tube which engages this knob. This knob helps with the opening of the umbrella.
  • the knob remains attached to the umbrella “handle”, and the guide wire used to pull the umbrella into position.
  • the device may also be made to open as a result of its construction material, for example, nitinol or polymer, elastically resuming its shape after being released from its sheath.
  • the umbrella When the umbrella is to be closed, a tube or sheath of larger diameter than the knob is extended over the guide wire until it engages the knob. The umbrella is pulled back so that it inverts and is enclosed in the tube for removal. Inverting the device assures that no trapped particles escape into the bloodstream.
  • the device is preferably constructed of polymer, fabric, metal, or a combination of these materials.
  • the device may also optionally be equipped with radio-opaque markers or other structural parts which are radio-opaque for aid in placement guidance.
  • Another embodiment of the device has a rolled edge.
  • the device may also have a flat porous edge.
  • Another embodiment of the device has no struts, but instead has a nitinol skeleton.
  • Another embodiment has multiple wires to position and anchor the device.
  • Another embodiment of the device has anchors at the edges which help to maintain its position during the procedure.
  • Another embodiment of the device is parachute-like, with a ring gasket at its edge.
  • the gasket would be held firmly in position over the ostia of the brachiocephalic and left common carotid arteries.
  • the billowy porous middle section would deflect or trap clot and debris on its exterior surface while causing minimal resistance in the aorta.
  • the middle portion would be inverted as it is removed by pulling on wires attached to its center, capturing any clot stuck to it.
  • the center of the device may comprise a screen, which fits more snugly against the aortic wall, with a very small profile, further preventing resistance to downstream aortic bloodflow. Again the device would be removed by inversion, capturing any debris stuck to it prior to removal.
  • the device may be round, oval or rectangular or of another shape to assist in sealing of the edge against the wall of the aorta, covering the ostia of both the brachiocephalic and left common carotid arteries and maintaining a low profile within the lumen of the aorta.
  • This device could be modified in size in another embodiment in order to be used to cover the ostia of different vessels.
  • the device may be coated with something which prevents clots (e.g., heparin).
  • the device may be deployed through an artery of the arm, or through the femoral artery.
  • the preferred method would be through the right arm, if possible, as this would allow the device to be pulled back against the aortic wall to place it ( FIG. 3 ).
  • the opening of the umbrella When deployed through the femoral artery ( FIG. 4 ), the opening of the umbrella would be different and the umbrella would be pushed against the aortic wall over the brachiocephalic and left common carotid openings rather than being pulled back.
  • a wire would be cannulated into the brachiocephalic artery in this case to ensure correct positioning of the device.
  • the device would be modified to allow this method of delivery and positioning.
  • the knob would be on the outside of the umbrella and the handle would be a firm catheter to allow pushing.
  • retrieval of the device would involve inversion and closing of the “umbrella” by drawstring or another method.
  • the deflector is delivered via percutaneous insertion into the right brachial artery and is guided into the aortic arch. There it is deployed and then pulled back into position to cover the ostia of the innominate and left common carotid arteries.
  • the device deflects embolic debris during aortic and cardiac procedures, allowing the flow of blood through into the cerebral circulation (carotid arteries) but not permitting the passage of particulate debris.
  • the deflector is delivered via percutaneous insertion into the femoral artery and is guided into the aortic arch. After catheterization of the innominate artery, the device is passed over the wire and brought into position covering the ostia of the innominate and left common carotid arteries.
  • FIGS. 3A-E percutaneous access to the circulation via the right arm is performed and a wire guided into the aortic arch after exiting the innominate artery.
  • the device is placed over the wire and guided into the aortic arch.
  • the covering outer sheath which encapsulates the device is retracted ( FIG. 3A ), exposing the device to the aortic bloodstream.
  • the device is then opened in the aortic arch ( FIG. 3B ).
  • the device is pulled back into position, covering the ostia of the innominate and left common carotid artery.
  • the device allows the passage of blood through to the carotid arteries, but deflects debris generated by aortic or cardiac surgery away from these arteries.
  • the device is closed by inverting the covering cap ( FIG. 3D ).
  • the device is then withdrawn into a covering sheath ( FIG. 3E ) to completely encapsulate it prior to removal from the arm access artery. Any trapped debris is enfolded within the closed cap, safely and securely within the covering sheath.
  • the innominate artery is catheterized with a wire placed via femoral access. Over the wire, the device is guided into position in the aortic arch, where it is deployed by unsheathing ( FIG. 4A ). The device is then pushed over the wire into position securely covering the ostia of the innominate and left common carotid arteries ( FIG. 4B ). The device allows the passage of blood through to the carotid arteries, but deflects debris generated by aortic or cardiac surgery away from these arteries. At the completion of the debris producing concomitant procedure, the device is closed by inverting the covering cap ( FIG. 4C ), shown here by means of drawstrings.
  • the device is then collapsed ( FIG. 4D ) and withdrawn into a covering sheath ( FIG. 4E ) to completely encapsulate it prior to removal from the femoral artery. Any trapped debris is enfolded within the closed cap, safely and securely within the covering sheath. The wire and device are then withdrawn from the femoral access.
  • the deflector of the present invention is dome-shaped with an adequate diameter to cover the ostia of both the brachiocephalic and left common carotid arteries, made of a material with pores to allow the flow of blood, but deflect or trap particles of a size which could cause a stroke.
  • the edge of the umbrella is a flexible, porous donut, similar to the edge of a diaphragm, allowing a good seal with the curved aortic wall.
  • the edge will preferably contain a nitinol wire ring.
  • the dome part of the umbrella has struts to assist in the opening and closing of the umbrella and to help maintain its position.
  • the center of the umbrella has a knob on the inside surface to which the struts are attached.
  • the device is pushed out of the delivery catheter with a tube which engages this knob.
  • This knob helps with the opening of the umbrella.
  • the knob remains attached to the umbrella “handle”, the guide wire used to pull the umbrella into position.
  • the device may also open as a result of the material it is made of, nitinol or polymer, resuming its shape after being released from its sheath.
  • the device is constructed of polymer, fabric, metal, or a combination of these materials.
  • the device may be provided with radioopaque markers or metal parts which are radioopaque.
  • Another embodiment of the device has a rolled edge.
  • the device could also have a flat porous edge.
  • Another embodiment of the device has no struts, but a nitinol skeleton.
  • Another embodiment has multiple wires to position and anchor the device.
  • Another embodiment of the device has anchors at the edges which help to maintain its position during the procedure.
  • Another embodiment of the device is parachute-like, with a ring gasket at its edge.
  • the gasket would be held firmly in position over the ostia of the brachiocephalic and left common carotid arteries.
  • the billowy porous middle section would deflect or trap clot and debris on its exterior surface while causing minimal resistance in the aorta.
  • the middle portion would be inverted as it is removed by pulling on wires attached to its center, capturing any clot stuck to it.
  • the center of the device could be a screen, which fits more snugly against the aortic wall, with a very small profile, further preventing resistance. Again the device would be removed by inversion, capturing any clot stuck to it prior to removal.
  • the device may be round, oval or rectangular or of another shape to assist in sealing of the edge against the wall of the aorta, covering the ostia of both the brachiocephalic and left common carotid arteries and maintaining a low profile within the lumen of the aorta.
  • This device could be modified in size in another embodiment in order to be used to cover the ostia of different vessels.
  • the device may be coated with something which prevents clots (e.g. heparin).

Abstract

An embolism deflection device and method for preventing embolization during a surgical procedure include a dome-shaped deflector, a catheter coupled to the deflector, and a delivery sheath. The deflector includes a frame and porous cover, the cover permitting blood flow therethrough while blocking emboli. The deflection device is deployable from a branch vessel to cover an ostium of the branch vessel to block emboli from a main vessel from entering the branch vessel.

Description

    CROSS-REFERENCE TO RELATED APPLICATIONS
  • This application is a continuation of U.S. application Ser. No. 11/518,865, filed Sep. 11, 2006, which issued as U.S. Pat. No. 8,460,335 on Jun. 11, 2013, the disclosure of which is incorporated by reference.
  • BACKGROUND OF THE INVENTION
  • Endovascular procedures are being used more and more frequently to treat various cardiac and vascular surgical problems. Blocked arteries can be treated with angioplasty, endarterectomy, and/or stenting, using minimally invasive endovascular approaches. Aneurysms can be repaired by endovascular techniques. Another use for endovascular surgery is the treatment of cardiac valvular disease. Valvuloplasties are already being done endovascularly and percutaneous valve replacement will surely follow, as it has already been tested in Europe. A major problem which is common to all these endovascular manipulations is that plaque found in the diseased vessels and valves can be dislodged and result in embolization. A major drawback to endovascular treatment of cardiac valves and arteries in the heart or thoracic aorta is that the dislodged debris can embolize into the carotid vessels resulting in catastrophic consequences such as stroke or even death. Attempts have been made to protect the cerebral vasculature with filters and other devices, but the inadequacy of the present art is obvious in the fact that these devices are rarely used. The plethora of pending patent applications for such protection devices suggests both the inadequacy of the present art and the need for improved devices.
  • The majority of devices described are filters. The problems with filters include difficulty in placement and retrieval as well as the possibility that a filter will fill abruptly causing blockage of the artery prior to removal of the filter. Cerebral protection requires placement of filters in the carotid arteries, which has the additional drawback of manipulation of the carotid vessels during filter placement while the cerebral vasculature is still unprotected. The risk of stroke for a carotid arteriogram done by cannulation of the carotid artery is 1% compared to an arteriogram done from injection into the aorta without selective cannulation which carries minimal risk. The risk of cannulating a carotid artery, navigating a catheter containing a filter into position, and deploying the filter would likely carry an even higher stroke risk. Patients requiring cardiac or aortic arch procedures are high risk candidates for having carotid disease. The chance of causing a stroke by the placement of the protective device into both carotid arteries makes the risk of using these devices prohibitive. The time and skill necessary to selectively cannulate both carotid arteries for filter placement has also contributed to the decision not to use them despite the stroke risk of unprotected cardiac and aortic arch procedures.
  • BRIEF DESCRIPTION OF THE INVENTION
  • The present invention comprises a deflector umbrella. In use, the invention is placed into the aortic arch by the Seldinger technique, preferably through the right arm but it may also be placed via the femoral artery. It is deployed in the aortic arch, where the umbrella is opened and pulled back into position to cover the ostia of both the brachiocephalic and left common carotid arteries.
  • BRIEF DESCRIPTION OF THE FIGURES
  • FIG. 1 depicts brachial artery insertion of the deflector of the present invention.
  • FIG. 2 depicts femoral artery insertion of the deflector of the present invention.
  • FIGS. 3A-E depict the preferred method of deployment of the deflector of the present invention through the patient's right arm, thus allowing the deflector to be pulled back against the aortic wall to place it.
  • FIGS. 4A-F depict an alternative method of deployment of the deflector of the present invention through the femoral artery wherein the deflector is pushed against the aortic wall over the brachiocephalic and left common carotid openings.
  • FIG. 5 depicts the deflector of the present invention.
  • DETAILED DESCRIPTION OF THE INVENTION
  • The deflector (“umbrella”) of the present invention is positioned prior to any manipulation of the heart or thoracic aorta. It is simple to place and carries only the risk of catheterizing the aorta through the arm or leg, which is minimal. The umbrella is opened in the thoracic aorta and positioned to cover the ostia of both the brachiocephalic and left common carotid arteries. This position prevents clots or debris from entering the cerebral circulation through either the right or left carotid arteries with one simple device. Any debris from the cardiac or aortic procedure is deflected downstream. After the procedure is complete, the umbrella is inverted by means of a sheath extended over the catheter wire, which then wholly or partially covers the inverted umbrella prior to withdrawal. Should any clot or debris be attached to the outer side of the umbrella, it will be captured in the inverted umbrella and withdrawn. A major advantage of the device is that one size fits all, so it can be kept available in stock.
  • The umbrella is preferably dome-shaped with an adequate diameter to cover the ostia of both the brachiocephalic and left common carotid arteries, made of a material with pores or similar openings or permeability to allow the flow of blood into the cerebral circulation, but able to deflect or trap particles of a size which could cause a stroke (as depicted in FIG. 5.) The edge of the umbrella is preferably a flexible, porous donut shape, similar to the edge of a vaginal diaphragm, allowing a good seal with the curved aortic wall. The edge will preferably contain a nitinol wire ring. The dome part of the umbrella preferably has struts or ribs to assist in the opening and closing of the umbrella and to help maintain its position. The center of the umbrella preferably has a knob or similar projection on the inside surface to which the struts are attached. The deflector is pushed out of the delivery catheter with a tube which engages this knob. This knob helps with the opening of the umbrella. The knob remains attached to the umbrella “handle”, and the guide wire used to pull the umbrella into position. The device may also be made to open as a result of its construction material, for example, nitinol or polymer, elastically resuming its shape after being released from its sheath.
  • When the umbrella is to be closed, a tube or sheath of larger diameter than the knob is extended over the guide wire until it engages the knob. The umbrella is pulled back so that it inverts and is enclosed in the tube for removal. Inverting the device assures that no trapped particles escape into the bloodstream. The device is preferably constructed of polymer, fabric, metal, or a combination of these materials. The device may also optionally be equipped with radio-opaque markers or other structural parts which are radio-opaque for aid in placement guidance.
  • Another embodiment of the device has a rolled edge.
  • The device may also have a flat porous edge.
  • Another embodiment of the device has no struts, but instead has a nitinol skeleton.
  • Another embodiment has multiple wires to position and anchor the device.
  • Another embodiment of the device has anchors at the edges which help to maintain its position during the procedure.
  • Another embodiment of the device is parachute-like, with a ring gasket at its edge. The gasket would be held firmly in position over the ostia of the brachiocephalic and left common carotid arteries. The billowy porous middle section would deflect or trap clot and debris on its exterior surface while causing minimal resistance in the aorta. The middle portion would be inverted as it is removed by pulling on wires attached to its center, capturing any clot stuck to it.
  • Alternatively, the center of the device may comprise a screen, which fits more snugly against the aortic wall, with a very small profile, further preventing resistance to downstream aortic bloodflow. Again the device would be removed by inversion, capturing any debris stuck to it prior to removal.
  • The device may be round, oval or rectangular or of another shape to assist in sealing of the edge against the wall of the aorta, covering the ostia of both the brachiocephalic and left common carotid arteries and maintaining a low profile within the lumen of the aorta.
  • This device could be modified in size in another embodiment in order to be used to cover the ostia of different vessels.
  • The device may be coated with something which prevents clots (e.g., heparin).
  • The device may be deployed through an artery of the arm, or through the femoral artery. The preferred method would be through the right arm, if possible, as this would allow the device to be pulled back against the aortic wall to place it (FIG. 3).
  • When deployed through the femoral artery (FIG. 4), the opening of the umbrella would be different and the umbrella would be pushed against the aortic wall over the brachiocephalic and left common carotid openings rather than being pulled back. A wire would be cannulated into the brachiocephalic artery in this case to ensure correct positioning of the device. The device would be modified to allow this method of delivery and positioning. In this embodiment, the knob would be on the outside of the umbrella and the handle would be a firm catheter to allow pushing. In this case, retrieval of the device would involve inversion and closing of the “umbrella” by drawstring or another method.
  • Brachial Artery Insertion of the Device
  • Referring now to FIG. 1, the deflector is delivered via percutaneous insertion into the right brachial artery and is guided into the aortic arch. There it is deployed and then pulled back into position to cover the ostia of the innominate and left common carotid arteries. The device deflects embolic debris during aortic and cardiac procedures, allowing the flow of blood through into the cerebral circulation (carotid arteries) but not permitting the passage of particulate debris.
  • Femoral Artery Insertion of the Device
  • Referring now to FIG. 2, the deflector is delivered via percutaneous insertion into the femoral artery and is guided into the aortic arch. After catheterization of the innominate artery, the device is passed over the wire and brought into position covering the ostia of the innominate and left common carotid arteries.
  • Deployment of the Device via Arm Approach
  • Referring now to FIGS. 3A-E, percutaneous access to the circulation via the right arm is performed and a wire guided into the aortic arch after exiting the innominate artery. The device is placed over the wire and guided into the aortic arch. The covering outer sheath which encapsulates the device is retracted (FIG. 3A), exposing the device to the aortic bloodstream. The device is then opened in the aortic arch (FIG. 3B). The device is pulled back into position, covering the ostia of the innominate and left common carotid artery. The device allows the passage of blood through to the carotid arteries, but deflects debris generated by aortic or cardiac surgery away from these arteries. At the completion of the debris producing concomitant procedure, the device is closed by inverting the covering cap (FIG. 3D). The device is then withdrawn into a covering sheath (FIG. 3E) to completely encapsulate it prior to removal from the arm access artery. Any trapped debris is enfolded within the closed cap, safely and securely within the covering sheath.
  • Deployment of the Device via Femoral Approach
  • Referring now to FIGS. 4A-F, the innominate artery is catheterized with a wire placed via femoral access. Over the wire, the device is guided into position in the aortic arch, where it is deployed by unsheathing (FIG. 4A). The device is then pushed over the wire into position securely covering the ostia of the innominate and left common carotid arteries (FIG. 4B). The device allows the passage of blood through to the carotid arteries, but deflects debris generated by aortic or cardiac surgery away from these arteries. At the completion of the debris producing concomitant procedure, the device is closed by inverting the covering cap (FIG. 4C), shown here by means of drawstrings. The device is then collapsed (FIG. 4D) and withdrawn into a covering sheath (FIG. 4E) to completely encapsulate it prior to removal from the femoral artery. Any trapped debris is enfolded within the closed cap, safely and securely within the covering sheath. The wire and device are then withdrawn from the femoral access.
  • Embolic Deflecting Device
  • Referring now to FIG. 5, the deflector of the present invention, viewed from above, is dome-shaped with an adequate diameter to cover the ostia of both the brachiocephalic and left common carotid arteries, made of a material with pores to allow the flow of blood, but deflect or trap particles of a size which could cause a stroke. The edge of the umbrella is a flexible, porous donut, similar to the edge of a diaphragm, allowing a good seal with the curved aortic wall. The edge will preferably contain a nitinol wire ring. The dome part of the umbrella has struts to assist in the opening and closing of the umbrella and to help maintain its position.
  • The center of the umbrella has a knob on the inside surface to which the struts are attached. The device is pushed out of the delivery catheter with a tube which engages this knob. This knob helps with the opening of the umbrella. The knob remains attached to the umbrella “handle”, the guide wire used to pull the umbrella into position. The device may also open as a result of the material it is made of, nitinol or polymer, resuming its shape after being released from its sheath.
  • The device is constructed of polymer, fabric, metal, or a combination of these materials. The device may be provided with radioopaque markers or metal parts which are radioopaque.
  • Another embodiment of the device has a rolled edge. The device could also have a flat porous edge. Another embodiment of the device has no struts, but a nitinol skeleton. Another embodiment has multiple wires to position and anchor the device. Another embodiment of the device has anchors at the edges which help to maintain its position during the procedure.
  • Another embodiment of the device is parachute-like, with a ring gasket at its edge. The gasket would be held firmly in position over the ostia of the brachiocephalic and left common carotid arteries. The billowy porous middle section would deflect or trap clot and debris on its exterior surface while causing minimal resistance in the aorta. The middle portion would be inverted as it is removed by pulling on wires attached to its center, capturing any clot stuck to it. Alternatively, the center of the device could be a screen, which fits more snugly against the aortic wall, with a very small profile, further preventing resistance. Again the device would be removed by inversion, capturing any clot stuck to it prior to removal.
  • The device may be round, oval or rectangular or of another shape to assist in sealing of the edge against the wall of the aorta, covering the ostia of both the brachiocephalic and left common carotid arteries and maintaining a low profile within the lumen of the aorta. This device could be modified in size in another embodiment in order to be used to cover the ostia of different vessels. The device may be coated with something which prevents clots (e.g. heparin).
  • While the invention has been described in its preferred embodiments, it is to be understood that the words which have been used are words of description rather than of limitation and that changes may be made within the purview of the appended claims without departing from the true scope and spirit of the invention in its broader aspects. Rather, various modifications may be made in the details within the scope and range of equivalents of the claims and without departing from the spirit of the invention. The inventor further requires that the scope accorded the claims be in accordance with the broadest possible construction available under the law as it exists on the date of filing hereof (and of the application from which this application obtains priority, if any) and that no narrowing of the scope of the appended claims be allowed due to subsequent changes in the law, as such a narrowing would constitute an ex post facto adjudication, and a taking without due process or just compensation.

Claims (14)

What is claimed is:
1. An embolic deflection device for preventing emboli from entering a brachiocephalic artery and a left common carotid artery from an aorta, the device comprising:
an expandable and collapsible, oval dome-shaped embolism deflector comprising a flexible nitinol frame and a porous, polymer cover secured to the frame, the frame comprising a plurality of struts extending from a central projection to a ring extending around an edge of the deflector, the cover permeable to blood and impermeable to emboli, the cover coated with heparin, the deflector comprising radiopaque markers, a diameter of the deflector sized to simultaneously cover an ostium of a brachiocephalic artery and an ostium of a left common carotid artery when the deflector is deployed from the brachiocephalic artery;
an elongate catheter, a distal end of the catheter coupled to the projection of the deflector; and
an elongate delivery sheath dimensioned for percutaneous insertion into an artery of a arm,
wherein the deflector is deployable from the delivery sheath and invertible back into the delivery sheath, and the edge of the deflector is sufficiently deformable to seal against an aortic wall around the ostium of the brachiocephalic artery and the ostium of the left common carotid artery when traction is applied to the elongate catheter.
2. The embolic deflection device of claim 1, wherein the artery of the arm is a right brachial artery.
3. An embolic deflection device for preventing emboli from entering a branch vessel from main vessel, the device comprising:
an expandable and collapsible, dome-shaped embolism deflector comprising a flexible frame and a porous cover secured to the frame, the frame comprising a plurality of struts extending from a central projection to a ring extending around an edge of the deflector, the cover permeable to blood and impermeable to emboli, a diameter of the deflector sized to simultaneously cover an ostium of a branch vessel when the deflector is deployed therefrom;
an elongate catheter, a distal end of the catheter coupled to the projection of the deflector; and
an elongate delivery sheath dimensioned for percutaneous insertion into the branch vessel,
wherein the deflector is deployable from the delivery sheath and invertible back into the delivery sheath, and the edge of the deflector is sufficiently deformable to seal against wall of a main vessel around the ostium of the branch vessel when traction is applied to the elongate catheter.
4. The embolic deflection device of claim 3, wherein deflector is round, oval, or rectangular.
5. The embolic deflection device of claim 3, wherein deflector is oval.
6. The embolic deflection device of claim 3, wherein deflector further comprises radiopaque markers.
7. The embolic deflection device of claim 3, wherein the frame is nitinol.
8. The embolic deflection device of claim 3, wherein the cover is coated with heparin.
9. The embolic deflection device of claim 3, wherein the cover is at least one of a fabric and polymer.
10. The embolic deflection device of claim 3, wherein the branch vessel is a brachiocephalic artery and the main vessel is an aorta.
11. The embolic deflection device of claim 3, wherein the branch vessel is a first branch vessel and the diameter of the deflector is sized to simultaneously cover the ostium of the first branch vessel and an ostium of a second branch vessel when the deflector is deployed from the first branch vessel.
12. The embolic deflection device of claim 11, wherein the first branch vessel is a brachiocephalic artery, the second branch vessel is a left common carotid artery, and the main vessel is an aorta.
13. The embolic deflection device of claim 3, wherein the delivery sheath is dimensioned for percutaneous delivery through an artery of a right arm.
14. The embolic deflection device of claim 13, wherein the artery of the right arm is a right brachial artery.
US13/911,692 2006-09-11 2013-06-06 Embolic protection device and method of use Abandoned US20130267993A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US13/911,692 US20130267993A1 (en) 2006-09-11 2013-06-06 Embolic protection device and method of use

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/518,865 US8460335B2 (en) 2006-09-11 2006-09-11 Method of deflecting emboli from the cerebral circulation
US13/911,692 US20130267993A1 (en) 2006-09-11 2013-06-06 Embolic protection device and method of use

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US11/518,865 Continuation US8460335B2 (en) 2006-09-11 2006-09-11 Method of deflecting emboli from the cerebral circulation

Publications (1)

Publication Number Publication Date
US20130267993A1 true US20130267993A1 (en) 2013-10-10

Family

ID=39170748

Family Applications (2)

Application Number Title Priority Date Filing Date
US11/518,865 Active 2031-03-23 US8460335B2 (en) 2006-09-11 2006-09-11 Method of deflecting emboli from the cerebral circulation
US13/911,692 Abandoned US20130267993A1 (en) 2006-09-11 2013-06-06 Embolic protection device and method of use

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US11/518,865 Active 2031-03-23 US8460335B2 (en) 2006-09-11 2006-09-11 Method of deflecting emboli from the cerebral circulation

Country Status (5)

Country Link
US (2) US8460335B2 (en)
EP (1) EP2059292B1 (en)
CA (1) CA2663207C (en)
IL (1) IL197526A0 (en)
WO (1) WO2008033845A2 (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9579116B1 (en) 2015-08-06 2017-02-28 Kp Medcure, Inc. Axial lengthening thrombus capture system
US9744024B2 (en) 2015-08-06 2017-08-29 Kp Medcure, Inc. Axial lengthening thrombus capture system
US9999493B2 (en) 2015-08-06 2018-06-19 Kp Medcure, Inc. Axial lengthening thrombus capture system
US10617507B2 (en) 2006-11-29 2020-04-14 Emboline, Inc. Embolic protection device
US10617509B2 (en) 2015-12-29 2020-04-14 Emboline, Inc. Multi-access intraprocedural embolic protection device
US10617510B2 (en) 2012-01-06 2020-04-14 Emboline, Inc. Introducer sheath with embolic protection
US10736728B2 (en) 2002-08-27 2020-08-11 Emboline, Inc. Embolic protection device
US11304792B2 (en) 2019-02-13 2022-04-19 Emboline, Inc. Catheter with integrated embolic protection device
US11793531B2 (en) 2019-11-05 2023-10-24 Vascular Medcure, Inc. Axial lengthening thrombus capture system, tensioning system and expandable funnel catheter
US11937957B2 (en) 2015-11-09 2024-03-26 Radiaction Ltd. Radiation shielding apparatuses and applications thereof

Families Citing this family (87)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7749245B2 (en) 2000-01-27 2010-07-06 Medtronic, Inc. Cardiac valve procedure methods and devices
ES2399091T3 (en) 2001-12-05 2013-03-25 Keystone Heart Ltd. Endovascular device for entrapment of particulate matter and method of use
CN101242785B (en) 2005-06-20 2010-11-03 苏图诺有限公司 Apparatus for applying a knot to a suture
US8062324B2 (en) * 2006-05-08 2011-11-22 S.M.T. Research And Development Ltd. Device and method for vascular filter
WO2008031033A2 (en) * 2006-09-07 2008-03-13 Spence Paul A Ultrasonic implant, systems and methods related to diverting material in blood flow away from the head
WO2010081025A1 (en) * 2009-01-09 2010-07-15 Embrella Cardiovascular, Inc. Embolic deflection device and method of use
US20100179583A1 (en) * 2006-09-11 2010-07-15 Carpenter Judith T Methods of deploying and retrieving an embolic diversion device
US20100179647A1 (en) * 2006-09-11 2010-07-15 Carpenter Judith T Methods of reducing embolism to cerebral circulation as a consequence of an index cardiac procedure
US9480548B2 (en) * 2006-09-11 2016-11-01 Edwards Lifesciences Ag Embolic protection device and method of use
US9339367B2 (en) 2006-09-11 2016-05-17 Edwards Lifesciences Ag Embolic deflection device
US20100324589A1 (en) * 2006-09-11 2010-12-23 Carpenter Judith T Embolic deflection device
JP2010512231A (en) * 2006-12-12 2010-04-22 スペンス、ポール・エー Implant, system and method for physically diverting substances in blood to avoid head
WO2008121738A2 (en) 2007-03-29 2008-10-09 Sutura, Inc. Suturing devices and methods for closing a patent foramen ovale
JP5385302B2 (en) * 2007-12-26 2014-01-08 ラザラス エフェクト, インコーポレイテッド Recovery system and method of use
AU2009232400B2 (en) 2008-04-03 2013-09-12 Cook Medical Technologies Llc Self cleaning devices, systems and methods of use
EP2633823B1 (en) * 2008-04-21 2016-06-01 Covidien LP Braid-ball embolic devices and delivery systems
US8771296B2 (en) 2008-05-09 2014-07-08 Nobles Medical Technologies Inc. Suturing devices and methods for suturing an anatomic valve
US9675482B2 (en) 2008-05-13 2017-06-13 Covidien Lp Braid implant delivery systems
WO2010008451A2 (en) 2008-06-23 2010-01-21 Lumen Biomedical, Inc. Embolic protection during percutaneous heart valve replacement and similar procedures
CA2731735A1 (en) * 2008-07-22 2010-01-28 Microtherapeutics, Inc. Vascular remodeling device
KR101772089B1 (en) 2008-09-04 2017-08-28 앤덜스 존슨 Temporary embolic protection device and medical procedure for delivery thereof
US8852225B2 (en) * 2008-09-25 2014-10-07 Medtronic, Inc. Emboli guarding device
EP2367505B1 (en) 2008-09-29 2020-08-12 Edwards Lifesciences CardiAQ LLC Heart valve
CA2739275C (en) 2008-10-01 2017-01-17 Impala, Inc. Delivery system for vascular implant
US9326843B2 (en) * 2009-01-16 2016-05-03 Claret Medical, Inc. Intravascular blood filters and methods of use
WO2010083527A2 (en) 2009-01-16 2010-07-22 Claret Medical, Inc. Intravascular blood filter
US20170202657A1 (en) 2009-01-16 2017-07-20 Claret Medical, Inc. Intravascular blood filters and methods of use
US8518073B2 (en) * 2009-01-29 2013-08-27 Claret Medical, Inc. Illuminated intravascular blood filter
CA2961053C (en) 2009-04-15 2019-04-30 Edwards Lifesciences Cardiaq Llc Vascular implant and delivery system
EP2459120A4 (en) * 2009-07-27 2017-11-01 Claret Medical, Inc. Dual endovascular filter and methods of use
EP3300691B1 (en) 2009-09-21 2021-06-30 Boston Scientific Scimed, Inc. Intravascular blood filters
US8845682B2 (en) * 2009-10-13 2014-09-30 E-Pacing, Inc. Vasculature closure devices and methods
US20110202085A1 (en) 2009-11-09 2011-08-18 Siddharth Loganathan Braid Ball Embolic Device Features
US9468442B2 (en) * 2010-01-28 2016-10-18 Covidien Lp Vascular remodeling device
EP2528541B1 (en) * 2010-01-28 2016-05-18 Covidien LP Vascular remodeling device
US8545552B2 (en) * 2010-02-26 2013-10-01 Silk Road Medical, Inc. Systems and methods for transcatheter aortic valve treatment
US8579964B2 (en) 2010-05-05 2013-11-12 Neovasc Inc. Transcatheter mitral valve prosthesis
US9345565B2 (en) 2010-12-30 2016-05-24 Claret Medical, Inc. Steerable dual filter cerebral protection system
CN103442653B (en) 2011-02-11 2016-06-01 柯惠有限合伙公司 Two benches launches aneurysma embolization device
GB2488596B (en) * 2011-03-04 2013-08-14 Cook Medical Technologies Llc Medical filtering devices and methods of use
WO2012134990A1 (en) 2011-03-25 2012-10-04 Tyco Healthcare Group Lp Vascular remodeling device
CN103889345B (en) 2011-04-15 2016-10-19 心脏缝合有限公司 For sewing up stitching devices and the method for anatomy lobe
US9308087B2 (en) 2011-04-28 2016-04-12 Neovasc Tiara Inc. Sequentially deployed transcatheter mitral valve prosthesis
US9554897B2 (en) 2011-04-28 2017-01-31 Neovasc Tiara Inc. Methods and apparatus for engaging a valve prosthesis with tissue
EP2522307B1 (en) * 2011-05-08 2020-09-30 ITSO Medical AB Device for delivery of medical devices to a cardiac valve
WO2013049448A1 (en) 2011-09-29 2013-04-04 Covidien Lp Vascular remodeling device
US9744023B2 (en) 2011-10-25 2017-08-29 Boston Scientific Scimed, Inc. Embolic debris deflector
US8968354B2 (en) 2011-10-26 2015-03-03 Boston Scientific Scimed, Inc. Extended protection embolic filter
EP2805515B1 (en) 2012-01-17 2022-10-05 Lumen Biomedical, Inc. Aortic arch filtration system for carotid artery protection
US9861464B2 (en) 2012-04-13 2018-01-09 Regents Of The University Of Minnesota Cardio-embolic stroke prevention
EP2852332B1 (en) 2012-05-11 2019-06-26 Heartstitch, Inc. Suturing devices for suturing an anatomic structure
US9345573B2 (en) 2012-05-30 2016-05-24 Neovasc Tiara Inc. Methods and apparatus for loading a prosthesis onto a delivery system
JP2015531630A (en) * 2012-08-23 2015-11-05 ミニマリー・インヴェイシヴ・サージカル・アクセス・リミテッド Direct aortic access system for transcatheter aortic valve surgery
US20140172006A1 (en) * 2012-08-24 2014-06-19 Synecor Llc System for facilitating transcatheter aortic valve procedures using femoral access
US9314248B2 (en) 2012-11-06 2016-04-19 Covidien Lp Multi-pivot thrombectomy device
US9414752B2 (en) 2012-11-09 2016-08-16 Elwha Llc Embolism deflector
KR102309795B1 (en) 2012-11-13 2021-10-08 코비디엔 엘피 Occlusive devices
US10307240B2 (en) * 2012-12-11 2019-06-04 Alan Zajarias Methods and apparatus for capturing embolic debris during endovascular procedures
US9295571B2 (en) 2013-01-17 2016-03-29 Covidien Lp Methods and apparatus for luminal stenting
US10285797B2 (en) 2013-01-22 2019-05-14 St. Jude Medical, Llc Protecting against cerebral embolism
US10583002B2 (en) 2013-03-11 2020-03-10 Neovasc Tiara Inc. Prosthetic valve with anti-pivoting mechanism
US9681951B2 (en) 2013-03-14 2017-06-20 Edwards Lifesciences Cardiaq Llc Prosthesis with outer skirt and anchors
US9463105B2 (en) 2013-03-14 2016-10-11 Covidien Lp Methods and apparatus for luminal stenting
CN108433769B (en) 2013-03-15 2021-06-08 柯惠有限合伙公司 Occlusion device
US9572665B2 (en) 2013-04-04 2017-02-21 Neovasc Tiara Inc. Methods and apparatus for delivering a prosthetic valve to a beating heart
CA2912886C (en) * 2013-05-14 2022-05-17 Transverse Medical, Inc. Catheter-based apparatuses and methods
EP3021762B1 (en) 2013-07-15 2020-03-04 E-Pacing, Inc. Vasculature closure devices
EP2859864A1 (en) 2013-10-14 2015-04-15 Protembis GmbH Medical device for embolic protection
JP6469109B2 (en) 2013-12-06 2019-02-13 メッド − ベンチャー インベストメンツ、エルエルシー Suture method and apparatus
EP3142598B1 (en) 2014-05-16 2020-07-08 Veosource SA Implantable self-cleaning blood filters
US10178993B2 (en) 2014-07-11 2019-01-15 Cardio Medical Solutions, Inc. Device and method for assisting end-to-side anastomosis
EP3622981A1 (en) 2015-04-10 2020-03-18 Silk Road Medical, Inc. Methods and systems for establishing retrograde carotid arterial blood flow
US9566144B2 (en) 2015-04-22 2017-02-14 Claret Medical, Inc. Vascular filters, deflectors, and methods
AU2016255848B2 (en) 2015-04-30 2020-10-01 Silk Road Medical, Inc. Systems and methods for transcatheter aortic valve treatment
US10478194B2 (en) 2015-09-23 2019-11-19 Covidien Lp Occlusive devices
EP4049618A1 (en) * 2016-03-10 2022-08-31 Keystone Heart Ltd. Intra-aortic device
EP3442437B1 (en) 2016-04-11 2020-11-11 Nobles Medical Technologies II, Inc. Tissue suturing device with suture spool
DE102016012869A1 (en) 2016-10-28 2018-05-03 Protembis Gmbh Embolic protection device, method for its folding and shaping device
EP4052679A1 (en) 2017-02-22 2022-09-07 Boston Scientific Scimed, Inc. Systems for protecting the cerebral vasculature
WO2018156948A1 (en) * 2017-02-23 2018-08-30 Boston Scientific Scimed, Inc. Medical drain device
US11839370B2 (en) 2017-06-19 2023-12-12 Heartstitch, Inc. Suturing devices and methods for suturing an opening in the apex of the heart
WO2019035095A1 (en) 2017-08-18 2019-02-21 Nobles Medical Technologies Ii, Inc. Apparatus for applying a knot to a suture
CN111565673A (en) 2017-10-27 2020-08-21 波士顿科学医学有限公司 System and method for protecting cerebral blood vessels
US11154390B2 (en) 2017-12-19 2021-10-26 Claret Medical, Inc. Systems for protection of the cerebral vasculature during a cardiac procedure
WO2019210118A1 (en) 2018-04-26 2019-10-31 Boston Scientific Scimed, Inc. Systems for protecting the cerebral vasculature
US11351023B2 (en) 2018-08-21 2022-06-07 Claret Medical, Inc. Systems and methods for protecting the cerebral vasculature
US11504816B2 (en) 2019-11-04 2022-11-22 Covidien Lp Systems and methods for treating aneurysms

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020095174A1 (en) * 1999-11-15 2002-07-18 Scimed Life Systems, Inc. Guidewire filter and methods of use
US20030158518A1 (en) * 2001-08-22 2003-08-21 Schonholz Claudio Javier Mechanical thrombectomy device for use in cerebral vessels
US20070225748A1 (en) * 2004-12-30 2007-09-27 Park Jin S Distal protection filter with improved wall apposition
US7727253B2 (en) * 2000-11-03 2010-06-01 Cook Incorporated Medical grasping device having embolic protection

Family Cites Families (92)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK151404C (en) 1984-05-23 1988-07-18 Cook Europ Aps William FULLY FILTER FOR IMPLANTATION IN A PATIENT'S BLOOD
DK124690D0 (en) 1990-05-18 1990-05-18 Henning Rud Andersen FAT PROTECTION FOR IMPLEMENTATION IN THE BODY FOR REPLACEMENT OF NATURAL FLEET AND CATS FOR USE IN IMPLEMENTING A SUCH FAT PROTECTION
US5634942A (en) 1994-04-21 1997-06-03 B. Braun Celsa Assembly comprising a blood filter for temporary or definitive use and a device for implanting it
DE69529338T3 (en) 1994-07-08 2007-05-31 Ev3 Inc., Plymouth Intravascular filter device
IL111634A0 (en) * 1994-11-14 1995-01-24 Mohr Asaf Computerized telephone apparatus
US5989281A (en) 1995-11-07 1999-11-23 Embol-X, Inc. Cannula with associated filter and methods of use during cardiac surgery
US5769816A (en) 1995-11-07 1998-06-23 Embol-X, Inc. Cannula with associated filter
US5695519A (en) 1995-11-30 1997-12-09 American Biomed, Inc. Percutaneous filter for carotid angioplasty
US5662671A (en) 1996-07-17 1997-09-02 Embol-X, Inc. Atherectomy device having trapping and excising means for removal of plaque from the aorta and other arteries
US6447530B1 (en) 1996-11-27 2002-09-10 Scimed Life Systems, Inc. Atraumatic anchoring and disengagement mechanism for permanent implant device
US5876367A (en) 1996-12-05 1999-03-02 Embol-X, Inc. Cerebral protection during carotid endarterectomy and downstream vascular protection during other surgeries
US6391044B1 (en) 1997-02-03 2002-05-21 Angioguard, Inc. Vascular filter system
US6152946A (en) 1998-03-05 2000-11-28 Scimed Life Systems, Inc. Distal protection device and method
US5911734A (en) 1997-05-08 1999-06-15 Embol-X, Inc. Percutaneous catheter and guidewire having filter and medical device deployment capabilities
US6743246B1 (en) 1997-05-08 2004-06-01 Edwards Lifesciences Corporation Devices and methods for protecting a patient from embolic material during surgery
US6258120B1 (en) * 1997-12-23 2001-07-10 Embol-X, Inc. Implantable cerebral protection device and methods of use
US6761727B1 (en) 1997-06-02 2004-07-13 Medtronic Ave, Inc. Filter assembly
US6245088B1 (en) * 1997-07-07 2001-06-12 Samuel R. Lowery Retrievable umbrella sieve and method of use
US6361545B1 (en) 1997-09-26 2002-03-26 Cardeon Corporation Perfusion filter catheter
US6395014B1 (en) 1997-09-26 2002-05-28 John A. Macoviak Cerebral embolic protection assembly and associated methods
US6371935B1 (en) 1999-01-22 2002-04-16 Cardeon Corporation Aortic catheter with flow divider and methods for preventing cerebral embolization
DE69838952T2 (en) 1997-11-07 2009-01-02 Salviac Ltd. EMBOLISM PROTECTION DEVICE
US6695864B2 (en) 1997-12-15 2004-02-24 Cardeon Corporation Method and apparatus for cerebral embolic protection
US6254563B1 (en) 1997-12-15 2001-07-03 Cardeon Corporation Perfusion shunt apparatus and method
AU5333599A (en) 1998-08-06 2000-02-28 Cardeon Corporation Aortic catheter with porous aortic arch balloon and methods for selective aorticperfusion
US7128073B1 (en) 1998-11-06 2006-10-31 Ev3 Endovascular, Inc. Method and device for left atrial appendage occlusion
US8016852B2 (en) 1998-11-10 2011-09-13 Stryker Corporation Bioactive components for incorporation with vaso-occlusive members
US20020138094A1 (en) 1999-02-12 2002-09-26 Thomas Borillo Vascular filter system
US20020169474A1 (en) 1999-03-08 2002-11-14 Microvena Corporation Minimally invasive medical device deployment and retrieval system
IL128938A0 (en) 1999-03-11 2000-02-17 Mind Guard Ltd Implantable stroke treating device
US20040167613A1 (en) 1999-03-11 2004-08-26 Ofer Yodfat Implantable stroke prevention device
US6673089B1 (en) 1999-03-11 2004-01-06 Mindguard Ltd. Implantable stroke treating device
CA2620783C (en) 1999-04-09 2011-04-05 Evalve, Inc. Methods and apparatus for cardiac valve repair
US7229463B2 (en) 1999-07-30 2007-06-12 Angioguard, Inc. Vascular filter system for cardiopulmonary bypass
US6142987A (en) 1999-08-03 2000-11-07 Scimed Life Systems, Inc. Guided filter with support wire and methods of use
US6346116B1 (en) 1999-08-03 2002-02-12 Medtronic Ave, Inc. Distal protection device
US6251122B1 (en) 1999-09-02 2001-06-26 Scimed Life Systems, Inc. Intravascular filter retrieval device and method
DE29916162U1 (en) 1999-09-14 2000-01-13 Cormedics Gmbh Vascular filter system
US6375670B1 (en) 1999-10-07 2002-04-23 Prodesco, Inc. Intraluminal filter
US6994092B2 (en) 1999-11-08 2006-02-07 Ev3 Sunnyvale, Inc. Device for containing embolic material in the LAA having a plurality of tissue retention structures
US20070043435A1 (en) 1999-11-17 2007-02-22 Jacques Seguin Non-cylindrical prosthetic valve system for transluminal delivery
US6540722B1 (en) 1999-12-30 2003-04-01 Advanced Cardiovascular Systems, Inc. Embolic protection devices
US6695813B1 (en) 1999-12-30 2004-02-24 Advanced Cardiovascular Systems, Inc. Embolic protection devices
US6361546B1 (en) 2000-01-13 2002-03-26 Endotex Interventional Systems, Inc. Deployable recoverable vascular filter and methods for use
US20040010308A1 (en) 2000-01-18 2004-01-15 Mindguard Ltd. Implantable composite device and corresponding method for deflecting embolic material in blood flowing at an arterial bifurcation
US20040010307A1 (en) 2000-01-18 2004-01-15 Mindguard Ltd. Implantable integral device and corresponding method for deflecting embolic material in blood flowing at an arterial bifurcation
GB2369575A (en) 2000-04-20 2002-06-05 Salviac Ltd An embolic protection system
US6706053B1 (en) 2000-04-28 2004-03-16 Advanced Cardiovascular Systems, Inc. Nitinol alloy design for sheath deployable and re-sheathable vascular devices
US6645221B1 (en) 2000-05-30 2003-11-11 Zuli, Holdings Ltd. Active arterial embolization filter
IL137326A0 (en) 2000-07-17 2001-07-24 Mind Guard Ltd Implantable braided stroke preventing device and method of manufacturing
US6616681B2 (en) 2000-10-05 2003-09-09 Scimed Life Systems, Inc. Filter delivery and retrieval device
US6616680B1 (en) 2000-11-01 2003-09-09 Joseph M. Thielen Distal protection and delivery system and method
US6626937B1 (en) 2000-11-14 2003-09-30 Advanced Cardiovascular Systems, Inc. Austenitic nitinol medical devices
US20020128680A1 (en) 2001-01-25 2002-09-12 Pavlovic Jennifer L. Distal protection device with electrospun polymer fiber matrix
US20020128679A1 (en) 2001-03-08 2002-09-12 Embol-X, Inc. Cerebral protection during carotid endarterectomy and methods of use
US6645223B2 (en) 2001-04-30 2003-11-11 Advanced Cardiovascular Systems, Inc. Deployment and recovery control systems for embolic protection devices
US6599307B1 (en) 2001-06-29 2003-07-29 Advanced Cardiovascular Systems, Inc. Filter device for embolic protection systems
US6951570B2 (en) 2001-07-02 2005-10-04 Rubicon Medical, Inc. Methods, systems, and devices for deploying a filter from a filter device
US6962598B2 (en) 2001-07-02 2005-11-08 Rubicon Medical, Inc. Methods, systems, and devices for providing embolic protection
FR2828263B1 (en) 2001-08-03 2007-05-11 Philipp Bonhoeffer DEVICE FOR IMPLANTATION OF AN IMPLANT AND METHOD FOR IMPLANTATION OF THE DEVICE
US6893460B2 (en) 2001-10-11 2005-05-17 Percutaneous Valve Technologies Inc. Implantable prosthetic valve
ES2399091T3 (en) 2001-12-05 2013-03-25 Keystone Heart Ltd. Endovascular device for entrapment of particulate matter and method of use
US7241304B2 (en) 2001-12-21 2007-07-10 Advanced Cardiovascular Systems, Inc. Flexible and conformable embolic filtering devices
US20030158574A1 (en) 2002-02-15 2003-08-21 Esch Brady D. Flow-through aortic flow divider for cerebral and coronary embolic protection
ATE369088T1 (en) 2002-03-05 2007-08-15 Salviac Ltd SYSTEM FOR PROTECTION AGAINST EMBOLIA
US8070769B2 (en) 2002-05-06 2011-12-06 Boston Scientific Scimed, Inc. Inverted embolic protection filter
US7172614B2 (en) 2002-06-27 2007-02-06 Advanced Cardiovascular Systems, Inc. Support structures for embolic filtering devices
US7303575B2 (en) 2002-08-01 2007-12-04 Lumen Biomedical, Inc. Embolism protection devices
US20040034386A1 (en) * 2002-08-19 2004-02-19 Michael Fulton Aneurysm stent
US8114114B2 (en) 2002-08-27 2012-02-14 Emboline, Inc. Embolic protection device
WO2004021922A2 (en) 2002-09-03 2004-03-18 Morrill Richard J Arterial embolic filter deployed from catheter
US7174636B2 (en) 2002-09-04 2007-02-13 Scimed Life Systems, Inc. Method of making an embolic filter
US7252675B2 (en) 2002-09-30 2007-08-07 Advanced Cardiovascular, Inc. Embolic filtering devices
US20040111111A1 (en) 2002-12-10 2004-06-10 Scimed Life Systems, Inc. Intravascular filter membrane with shape memory
US7323001B2 (en) 2003-01-30 2008-01-29 Ev3 Inc. Embolic filters with controlled pore size
US7879062B2 (en) 2003-07-22 2011-02-01 Lumen Biomedical, Inc. Fiber based embolism protection device
US7604650B2 (en) 2003-10-06 2009-10-20 3F Therapeutics, Inc. Method and assembly for distal embolic protection
US20050267516A1 (en) 2004-06-01 2005-12-01 Farzad Soleimani Embolic protection device for the prevention of stroke
WO2006055052A2 (en) 2004-07-19 2006-05-26 Michael Gertner Methods and devices for chronic embolic protection
US7927346B2 (en) 2004-09-10 2011-04-19 Stryker Corporation Diversion device to increase cerebral blood flow
US20060241677A1 (en) 2005-01-03 2006-10-26 Eric Johnson Methods for maintaining a filtering device within a lumen
US20060161241A1 (en) 2005-01-14 2006-07-20 Denise Barbut Methods and devices for treating aortic atheroma
US20060253148A1 (en) 2005-05-04 2006-11-09 Leone James E Apparatus and method of using an occluder for embolic protection
US20080255603A1 (en) 2005-06-10 2008-10-16 Sagax, Inc. Implant Device Particularly Useful For Implantation In the Intravascular System For Diverting Emboli
US7850708B2 (en) 2005-06-20 2010-12-14 Cook Incorporated Embolic protection device having a reticulated body with staggered struts
US8062324B2 (en) 2006-05-08 2011-11-22 S.M.T. Research And Development Ltd. Device and method for vascular filter
US20080109055A1 (en) 2006-11-02 2008-05-08 Sage Medical Technologies, Inc. Implant for aortic dissection and methods of use
US20080114440A1 (en) 2006-11-13 2008-05-15 Sage Medical Technologies, Inc Methods and devices for deploying an implant in curved anatomy
EP2129425B1 (en) 2006-11-29 2023-12-27 Emboline, INC. Embolic protection device
JP5593545B2 (en) 2006-12-06 2014-09-24 メドトロニック シーブイ ルクセンブルク エス.アー.エール.エル. System and method for transapical delivery of a self-expanding valve secured to an annulus
JP2010512231A (en) 2006-12-12 2010-04-22 スペンス、ポール・エー Implant, system and method for physically diverting substances in blood to avoid head
US20080275489A1 (en) 2007-05-01 2008-11-06 Thomas Frank Kinst Removable medical filter

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020095174A1 (en) * 1999-11-15 2002-07-18 Scimed Life Systems, Inc. Guidewire filter and methods of use
US7727253B2 (en) * 2000-11-03 2010-06-01 Cook Incorporated Medical grasping device having embolic protection
US20030158518A1 (en) * 2001-08-22 2003-08-21 Schonholz Claudio Javier Mechanical thrombectomy device for use in cerebral vessels
US20070225748A1 (en) * 2004-12-30 2007-09-27 Park Jin S Distal protection filter with improved wall apposition

Cited By (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10881494B2 (en) 2002-08-27 2021-01-05 Emboline, Inc. Embolic protection device
US10736728B2 (en) 2002-08-27 2020-08-11 Emboline, Inc. Embolic protection device
US10617507B2 (en) 2006-11-29 2020-04-14 Emboline, Inc. Embolic protection device
US10939987B2 (en) 2006-11-29 2021-03-09 Emboline, Inc. Embolic protection device
US11051927B2 (en) 2012-01-06 2021-07-06 Emboline, Inc. Integrated embolic protection devices
US10617510B2 (en) 2012-01-06 2020-04-14 Emboline, Inc. Introducer sheath with embolic protection
US10070879B2 (en) 2015-08-06 2018-09-11 Kp Medcure, Inc. Axial lengthening thrombus capture system
US11490913B2 (en) 2015-08-06 2022-11-08 Vascular Medcure, Inc. Axial lengthening thrombus capture system
US10376275B2 (en) 2015-08-06 2019-08-13 Kp Medcure, Inc. Axial lengthening thrombus capture system
US10456236B2 (en) 2015-08-06 2019-10-29 Kp Medcure, Inc. Axial lengthening thrombus capture system
US10512479B2 (en) 2015-08-06 2019-12-24 Kp Medcure, Inc. Axial lengthening thrombus capture system
US10143482B2 (en) 2015-08-06 2018-12-04 Kp Medcure, Inc. Axial lengthening thrombus capture system
US9579116B1 (en) 2015-08-06 2017-02-28 Kp Medcure, Inc. Axial lengthening thrombus capture system
US10238482B2 (en) 2015-08-06 2019-03-26 Kp Medcure, Inc. Axial lengthening thrombus capture system
US9999493B2 (en) 2015-08-06 2018-06-19 Kp Medcure, Inc. Axial lengthening thrombus capture system
US9844386B2 (en) 2015-08-06 2017-12-19 Kp Medcure, Inc. Axial lengthening thrombus capture system
US9744024B2 (en) 2015-08-06 2017-08-29 Kp Medcure, Inc. Axial lengthening thrombus capture system
US9636206B2 (en) 2015-08-06 2017-05-02 Kp Medcure, Inc. Axial lengthening thrombus capture system
US11471175B2 (en) 2015-08-06 2022-10-18 Vascular Medcure, Inc. Axial lengthening thrombus capture system
US11510691B2 (en) 2015-08-06 2022-11-29 Vascular Medcure, Inc. Axial lengthening thrombus capture system
US11937957B2 (en) 2015-11-09 2024-03-26 Radiaction Ltd. Radiation shielding apparatuses and applications thereof
US10617509B2 (en) 2015-12-29 2020-04-14 Emboline, Inc. Multi-access intraprocedural embolic protection device
US11399927B2 (en) 2015-12-29 2022-08-02 Emboline, Inc. Multi-access intraprocedural embolic protection device
US11304792B2 (en) 2019-02-13 2022-04-19 Emboline, Inc. Catheter with integrated embolic protection device
US11793531B2 (en) 2019-11-05 2023-10-24 Vascular Medcure, Inc. Axial lengthening thrombus capture system, tensioning system and expandable funnel catheter

Also Published As

Publication number Publication date
EP2059292B1 (en) 2015-11-11
US8460335B2 (en) 2013-06-11
EP2059292A2 (en) 2009-05-20
CA2663207C (en) 2014-12-16
US20080065145A1 (en) 2008-03-13
WO2008033845A2 (en) 2008-03-20
WO2008033845A3 (en) 2008-12-24
IL197526A0 (en) 2009-12-24
EP2059292A4 (en) 2011-02-02
CA2663207A1 (en) 2008-03-20

Similar Documents

Publication Publication Date Title
US8460335B2 (en) Method of deflecting emboli from the cerebral circulation
US11191631B2 (en) Dual endovascular filter and methods of use
US20210315680A1 (en) Integrated embolic protection decives
US9480548B2 (en) Embolic protection device and method of use
US11020211B2 (en) Accessory device to provide neuroprotection during interventional procedures
US6371970B1 (en) Vascular filter having articulation region and methods of use in the ascending aorta
US20140074148A1 (en) Embolic protection system and method for use in an aortic arch
US9962252B2 (en) Aortic great vessel protection
JP6612854B2 (en) Introducing sheath with embolic protection
US20170325930A1 (en) Filter and occluder systems and associated methods and devices
US10285797B2 (en) Protecting against cerebral embolism
WO2013126618A1 (en) Embolic protection system and method for use in an aortic arch

Legal Events

Date Code Title Description
AS Assignment

Owner name: EDWARDS LIFESCIENCES AG, SWITZERLAND

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:EMBRELLA CARDIOVASCULAR, INC.;REEL/FRAME:031201/0594

Effective date: 20110831

Owner name: EMBRELLA CARDIOVASCULAR, INC., PENNSYLVANIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:CARPENTER, JUDITH, MD;REEL/FRAME:031201/0419

Effective date: 20090530

Owner name: EMBRELLA CARDIOVASCULAR, INC., PENNSYLVANIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:CARPENTER, JUDITH T.;REEL/FRAME:031201/0498

Effective date: 20100415

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION